INNATE PHARMA

The current price of IPH is 2.150 EUR — it has decreased by 0.46% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange INNATE PHARMA stocks are traded under the ticker IPH.

INNATE PHARMA is going to release the next earnings report on Sep 12, 2024. Keep track of upcoming events with our Earnings Calendar.

IPH stock is 2.35% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is INNATE PHARMA there?

One year price forecast for INNATE PHARMA has a max estimate of 10.695 EUR and a min estimate of 2.250 EUR.

IPH earnings for the last quarter are 0.02 EUR whereas the estimation was 0.08 EUR which accounts for −75.00% surprise. Estimated earnings for the next quarter are −0.40 EUR. See more details about INNATE PHARMA earnings.

INNATE PHARMA revenue for the last quarter amounts to ‪40.20 M‬ EUR despite the estimated figure of ‪63.88 M‬ EUR. In the next quarter revenue is expected to reach ‪16.82 M‬ EUR.

Yes, you can track INNATE PHARMA financials in yearly and quarterly reports right on TradingView.

IPH net income for the last quarter is ‪−9.29 M‬ EUR, while the quarter before that showed ‪1.72 M‬ EUR of net income which accounts for −640.63% change. Track more INNATE PHARMA financial stats to get the full picture.

Today INNATE PHARMA has the market capitalization of ‪174.62 M‬, it has increased by 4.93% over the last week.

No, IPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, IPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNATE PHARMA stock right from TradingView charts — choose your broker and connect to your account.

IPH reached its all-time high on Apr 27, 2015 with the price of 17.850 EUR, and its all-time low was 1.060 EUR and was reached on Oct 10, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 179.00 employees. See our rating of the largest employees — is INNATE PHARMA on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNATE PHARMA technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNATE PHARMA stock shows the sell signal. See more of INNATE PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on INNATE PHARMA future price: according to them, IPH price has a max estimate of 10.69 EUR and a min estimate of 2.25 EUR. Read a more detailed INNATE PHARMA forecast: see what analysts think of INNATE PHARMA and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNATE PHARMA EBITDA is ‪−17.32 M‬ EUR, and current EBITDA margin is −33.36%. See more stats in INNATE PHARMA financial statements.